Lineage Cell Therapeutics Inc (LCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 27,207 | 29,827 | 36,838 | 16,662 | 19,650 |
| Marketable Securities | 1,948 | 1,552 | 1,337 | 1,511 | 1,220 |
| Receivables | 3,769 | 2,998 | 3,046 | 3,698 | 3,066 |
| TOTAL | $34,495 | $36,126 | $42,623 | $23,225 | $25,525 |
| Non-Current Assets | |||||
| PPE Net | 5,014 | 5,366 | 5,533 | 5,423 | 5,240 |
| Investments And Advances | 66,778 | 62,350 | 117,167 | 184,732 | 153,510 |
| Intangibles | 5,735 | 6,317 | 6,900 | 7,482 | 8,064 |
| Other Non-Current Assets | 229 | 236 | 1,018 | 1,005 | 1,014 |
| TOTAL | $77,756 | $74,269 | $130,618 | $198,642 | $167,828 |
| Total Assets | $112,251 | $110,395 | $173,241 | $221,867 | $193,353 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,028 | 4,703 | 5,718 | 5,360 | 5,130 |
| Other current liabilities | N/A | N/A | N/A | N/A | 5,100 |
| TOTAL | $5,843 | $5,810 | $6,879 | $6,012 | $13,530 |
| Non-Current Liabilities | |||||
| Long Term Debt | 0 | 0 | 18 | 44 | 95 |
| Deferred Revenues | 470 | 765 | 797 | 513 | 621 |
| Other Non-Current Liabilities | 1,783 | 2,044 | 1,982 | 2,146 | 1,886 |
| TOTAL | $1,657 | $2,130 | $2,099 | $6,868 | $1,638 |
| Total Liabilities | $7,500 | $7,940 | $8,978 | $12,880 | $15,168 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 126,877 | 126,873 | 126,869 | 126,866 | 115,804 |
| Common Shares | 383,529 | 379,186 | 378,487 | 342,508 | 334,538 |
| Retained earnings | -283,630 | -279,416 | -216,297 | -144,363 | -158,684 |
| Other shareholders' equity | 4,852 | 2,685 | 2,073 | 10,842 | 2,331 |
| TOTAL | $104,751 | $102,455 | $164,263 | $208,987 | $178,185 |
| Total Liabilities And Equity | $112,251 | $110,395 | $173,241 | $221,867 | $193,353 |